Patient Engagement Best Practices: The Benefits Without the Risks

Discover how to get the most out of your patient engagement programs while protecting your brand from regulatory non-compliance. 

Life Science companies are increasingly providing treatment-related items and services to support patients, such as nebulizers, utilization tracking tools, and home health visits. Proactive engagement strategies can achieve a host of critical objectives—from increasing medication adherence to informing clinical studies to shedding new light on the patient journey. They also, however, can present potential regulatory pitfalls.

How can you engage patients effectively while protecting your company from regulatory risks? How can you provide benefits to patients while keeping your brand safe? What are the challenges to patient engagement—and how can you overcome them? Manatt Health provides the answers in a new CLE-eligible webinar.

Key topics include:

  • A look at real-world patient engagement and benefit programs through the regulatory lens of the Beneficiary Inducement Statute and the Anti-Kickback Statute

  • An analysis of services, products and information provided in patient programs—and whether they qualify for safe harbor protections, such as access to care and nominal value exceptions

  • A review of real-world case studies demonstrating whether it is acceptable to tie certain benefits to particular brands

  • A guide to best practices that optimize program effectiveness while ensuring regulatory compliance



ShareVault’s secure document sharing solution gives organizations of all sizes in all industries the confidence to simply and securely share sensitive documents with third parties during due diligence, fundraising, board communications, and any circumstance when it is crucial that confidential information is maintained under the highest level of security and control.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.

featured Presenter:

Company team

Jeremy Lutsky

Counsel, Manatt Health

Jeremy Lutsky has over 20 years of deep FDA regulatory, transactional and in-house compliance experience, including ten-plus years working in-house with several prominent biotech and medical device companies. With an intimate understanding of the needs and inner workings of the pharmaceutical and medical device spaces, he provides counsel on a wide range of legal and regulatory matters, including FDA compliance, contracting, transactions, M&A, advertising, sponsorships and promotional review.

Before joining Manatt, Jeremy served as senior legal and compliance counsel for a leading biopharmaceutical manufacturing company, where he was the primary legal contact for all regulatory and compliance matters related to the company’s antibiotic product and co-promoted respiratory product. He worked with internal teams across sales, marketing, finance and HR to advise on commercial and regulatory issues ranging from advertising and promotions, fraud and abuse laws, pricing and reimbursement, contracting and HCP advisory boards, and consulting relationships.

As a member of the commercial leadership team, Jeremy provided not only legal and compliance guidance but also input on cutting-edge initiatives such as patient assistance programs and market access. In addition, he was relied upon to keep the team abreast of new regulatory developments, such as the recent guidance documents on payor communications and medical product communications that are consistent with approved labeling.

Jeremy has deep experience developing and implementing programs that ensure compliance with federal and state laws, including the False Claims Act, the Anti-Kickback Statute, Pharmaceutical Research and Manufacturers of America and Advanced Medical Technology Association codes, the Sunshine Act, and other FDA/Office of Inspector General guidance. He has also led the compliance function for multiple pharma and device companies. Jeremy’s experience includes drafting and rolling out relevant policies and procedures; conducting in-person and online training, auditing and monitoring to ensure compliance; and conducting investigations when necessary.
As a former senior associate for a large national law firm and corporate counsel to a specialty pharmaceutical and wound care company, Jeremy has also represented hospitals, academic medical centers, health plans and other related health systems on a variety of regulatory compliance and transactional matters. Learn More